UCL Institute of Immunity and Transplantation, Pears Building, Royal Free Campus, London, UK.
Methods Mol Biol. 2023;2559:171-187. doi: 10.1007/978-1-0716-2647-4_12.
Regulatory T Cells (Tregs) constitutively express the inhibitory receptor CTLA-4, which is fundamental to their role in immune suppression. Mechanistically, CTLA-4 on Tregs can attenuate T cell activation by physically removing and internalizing costimulatory ligands CD80 and CD86 from the surface of antigen-presenting cells by transendocytosis. Therefore, the process of transendocytosis can be harnessed as a tool to study the molecular basis of CTLA-4 biology and a key aspect of Treg suppressive function. In this chapter, we describe a method of human Treg isolation and expansion resulting in high CTLA-4 expression. We then detail a transendocytosis assay using artificial antigen-presenting cells (DG-75 B Cell lines) expressing fluorescently tagged ligands mixed with the expanded Tregs. This methodology can be applied to testing of patients carrying CTLA-4 mutations, providing a robust model to assess the degree of functional disruption.
调节性 T 细胞(Tregs)组成性表达抑制性受体 CTLA-4,这对其免疫抑制作用至关重要。从机制上讲,Tregs 上的 CTLA-4 可以通过胞吞作用从抗原呈递细胞表面物理去除和内化共刺激配体 CD80 和 CD86,从而减弱 T 细胞的激活。因此,胞吞作用过程可以被用作研究 CTLA-4 生物学基础和 Treg 抑制功能的关键方面的工具。在本章中,我们描述了一种从人类中分离和扩增 Treg 的方法,该方法导致 CTLA-4 的高表达。然后,我们详细介绍了一种使用表达荧光标记配体的人工抗原呈递细胞(DG-75 B 细胞系)与扩增的 Treg 混合的胞吞作用测定法。这种方法可用于测试携带 CTLA-4 突变的患者,提供了一种评估功能破坏程度的稳健模型。